Waters Corporation (WAT) Financials
WAT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 24.8 billion | 9.6 billion |
| March 31, 2026 | 24.5 billion | 9.2 billion |
| Dec. 31, 2025 | 5.1 billion | 2.5 billion |
| Sept. 30, 2025 | 4.9 billion | 2.5 billion |
WAT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 151.0 million | 25.0 million |
| March 31, 2026 | -42.0 million | 20.0 million |
| Dec. 31, 2025 | 125.6 million | 14.5 million |
| Sept. 30, 2025 | 161.9 million | 13.7 million |
WAT Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | -136.0 million |
| March 31, 2026 | -72.0 million |
| Dec. 31, 2025 | 225.2 million |
| Sept. 30, 2025 | 148.9 million |
WAT Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 539.0 million | 5.1 billion | - |
| March 31, 2026 | 462.0 million | 4.9 billion | 355.0 million |
| Dec. 31, 2025 | 587.8 million | 947.4 million | 83.6 million |
| Sept. 30, 2025 | 459.1 million | 947.2 million | 79.0 million |
WAT Shares Outstanding
WAT Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 49.0 million | 122.0 million | 405.0 million | - |
| March 31, 2026 | 39.0 million | 96.0 million | 394.0 million | - |
| Dec. 31, 2025 | 39.0 million | 50.1 million | 196.7 million | - |
| Sept. 30, 2025 | 25.4 million | 53.6 million | 214.2 million | - |
WAT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 1.6 billion | 911.0 million |
| March 31, 2026 | 1.3 billion | 672.0 million |
| Dec. 31, 2025 | 932.4 million | 374.9 million |
| Sept. 30, 2025 | 799.9 million | 327.8 million |
WAT Revenue by Segment
Graph available only for paid members. Upgrade to see it.
WAT
Price: $409.38
52 week price:
Payout Ratio Range:
Earnings Per Share: 3.96 USD
P/E Ratio: 102.74
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 305400
Ebitda: 257.9 millionMarket Capitalization: 30.8 billion